Human milk oligosaccharides and their potential benefits for the breast-fed neonate

Minerva Pediatrica

Volumn 64, Issue 1, 2012, Pages 83-99

  Jantscher Krenn, E ^a   Bode, L ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Breastfeeding; Metabolism; Milk, human

Indexed keywords

GALACTOSYLTRANSFERASE; LACTOSE; OLIGOSACCHARIDE; PROBIOTIC AGENT;

ABSORPTION; ARTIFICIAL MILK; BIOSYNTHESIS; BRAIN DEVELOPMENT; BREAST FEEDING; BREAST MILK; CARBOHYDRATE ANALYSIS; CARBOHYDRATE METABOLISM; CLOSTRIDIUM; COLON; ENTEROCOCCUS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; LACTOBACILLUS; NEWBORN; PATHOGENESIS; REVIEW; RUMINOCOCCUS; SALMONELLOSIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS;

BACTERIAL INFECTIONS; BREAST FEEDING; HUMANS; INFANT FORMULA; INFANT, NEWBORN; MILK, HUMAN; OLIGOSACCHARIDES; PREBIOTICS;

EID: 84860280339     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. György P NR, Rose CS. Bifidus factor I. A variant of Lactobacillus bifidus requiring a special growth factor. Arch Biochem Biophys 1954;48: 193-201.
2. Kobata A. Structures and application of oligosaccharides in human milk. Proc Jpn Acad Ser B Phys Biol Sci 2010;86:731-47.
3. Ninonuevo MR, Park Y, Yin H, Zhang J, Ward RE, Clowers BH et al. A strategy for annotating the human milk glycome. J Agric Food Chem 2006;54:7471-80. (Pubitemid 44645760)
4. Wu S, Tao N, German JB, Grimm R, Lebrilla CB. Development of an annotated library of neutral human milk oligosaccharides. J Proteome Res 2010;9:4138-51.
5. Bode L. Human milk oligosaccharides: prebiotics and beyond. Nutr Rev 2009;67(Suppl 2):S183-91.
6. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 2000;20:699-722.
7. Chaturvedi P, Warren CD, Altaye M, Morrow AL, Ruiz-Palacios G, Pickering LK et al. Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 2001;11:365-72. (Pubitemid 32685211)
8. Thurl S, Munzert M, Henker J, Boehm G, Muller-Werner B, Jelinek J et al. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. Br J Nutr 2010;104:1261-71.
9. Leo F, Asakuma S, Fukuda K, Senda A, Urashima T. Determination of sialyl and neutral oligosaccharide levels in transition and mature milks of Samoan women, using anthranilic derivatization followed by reverse phase high performance liquid chromatography. Biosci Biotechnol Biochem 2010;74:298-303.
10. Martin-Sosa S, Martin MJ, Garcia-Pardo LA, Hueso P. Sialyloligosaccharides in human and bovine milk and in infant formulas: variations with the progression of lactation. J Dairy Sci 2003;86:52-9. (Pubitemid 39067160)
11. Rajput B, Shaper NL, Shaper JH. Transcriptional regulation of murine beta1,4-galactosyltransferase in somatic cells. Analysis of a gene that serves both a housekeeping and a mammary gland-specific function. J Biol Chem 1996;271:5131-42.
12. Fuhrer A, Sprenger N, Kurakevich E, Borsig L, Chassard C, Hennet T. Milk sialyllactose influences colitis in mice through selective intestinal bacterial colonization. J Exp Med 2010;207:2843-54.
13. Sabharwal H, Nilsson B, Chester MA, Lindh F, Gronberg G, Sjoblad S et al. Oligosaccharides from faeces of a blood-group B, breast-fed infant. Carbohydr Res 1988;178:145-54.
14. Sabharwal H, Nilsson B, Gronberg G, Chester MA, Dakour J, Sjoblad S et al. Oligosaccharides from feces of preterm infants fed on breast milk. Arch Biochem Biophys 1988;265:390-406.
15. Sabharwal H, Sjoblad S, Lundblad A. Sialylated oligosaccharides in human milk and feces of preterm, full-term, and weaning infants. J Pediatr Gastroenterol Nutr 1991;12:480-4.
16. Sabharwal H, Sjoblad S, Lundblad A. Affinity chromatographic identification and quantitation of blood group A-active oligosaccharides in human milk and feces of breast-fed infants. J Pediatr Gastroenterol Nutr 1991;12:474-9.
17. Sabharwal H, Nilsson B, Chester MA, Sjoblad S, Lundblad A. Blood group specific oligosaccharides from faeces of a blood group A breast-fed infant. Mol Immunol 1984;21:1105-12. (Pubitemid 15193739)
18. Chaturvedi P, Warren CD, Buescher CR, Pickering LK, Newburg DS. Survival of human milk oligosaccharides in the intestine of infants. Adv Exp Med Biol 2001;501:315-23. (Pubitemid 34102211)
19. Engfer MB, Stahl B, Finke B, Sawatzki G, Daniel H. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr 2000;71:1589-96. (Pubitemid 30395909)
20. Gnoth MJ, Kunz C, Kinne-Saffran E, Rudloff S. Human milk oligosaccharides are minimally digested in vitro. J Nutr 2000;130:3014-20. (Pubitemid 32005332)
21. Coppa GV, Pierani P, Zampini L, Bruni S, Carloni I, Gabrielli O. Characterization of oligosaccharides in milk and feces of breast-fed infants by high-performance anion-exchange chromatography. Adv Exp Med Biol 2001;501:307-14. (Pubitemid 34102210)
22. Albrecht S, Schols HA, van Zoeren D, van Lingen RA, Groot Jebbink LJ, van den Heuvel EG et al. Oligosaccharides in feces of breast- and formula-fed babies. Carbohydr Res 2011;346:2173-81.
23. Albrecht S, Schols HA, van den Heuvel EG, Voragen AG, Gruppen H. Occurrence of oligosaccharides in feces of breast-fed babies in their first six months of life and the corresponding breast milk. Carbohydr Res 2011;346:2540-50.
24. Rudloff S, Pohlentz G, Diekmann L, Egge H, Kunz C. Urinary excretion of lactose and oligosaccharides in preterm infants fed human milk or infant formula. Acta Paediatr 1996;85:598-603. (Pubitemid 26178509)
25. Rudloff S, Obermeier S, Borsch C, Pohlentz G, Hartmann R, Brosicke H et al. Incorporation of orally applied (13)C-galactose into milk lactose and oligosaccharides. Glycobiology 2006;16:477-87. (Pubitemid 43779044)
26. Rudloff S, Pohlentz G, Borsch C, Lentze MJ, Kunz C. Urinary excretion of in vivo 13C-labelled milk oligosaccharides in breastfed infants. BrJ Nutr 2011:1-7.
27. Gnoth MJ, Rudloff S, Kunz C, Kinne RK. Investigations of the in vitro transport of human milk oligosaccharides by a Caco-2 monolayer using a novel high performance liquid chromatography-mass spectrometry technique. J Biol Chem 2001;276:34363-70.
28. Hallgren P, Lindberg BS, Lundblad A. Quantitation of some urinary oligosaccharides during pregnancy and lactation. J Biol Chem 1977;252:1034-40. (Pubitemid 8041900)
29. Coppa GV, Gabrielli O, Giorgi P, Catassi C, Montanari MP, Varaldo PE et al. Preliminary study of breastfeeding and bacterial adhesion to uroepithelial cells. Lancet 1990;335:569-71. (Pubitemid 20089242)
30. Moro E. Morphologische und bakteriologische Untersuchungen über die Darmbakterien des Säuglings: die Bakterienflora des normalen Frauenmilchstuhls. Jahrbuch Kinderh 1900;61:686-734.
31. Morelli L. Postnatal development of intestinal microflora as influenced by infant nutrition. J Nutr 2008;138:1791S-5S.
32. Adlerberth I, Wold AE. Establishment of the gut microbiota in Western infants. Acta Paediatr 2009;98:229-38.
33. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002;68:219-26. (Pubitemid 34031183)
34. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 2000;30:61-7. (Pubitemid 30349947)
35. Bezirtzoglou E, Tsiotsias A, Welling GW Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe 2011 [Epub ahead of print].
36. Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB. In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Appl Environ Microbiol 2006;72:4497-9. (Pubitemid 43894931)
37. LoCascio RG, Ninonuevo MR, Freeman SL, Sela DA, Grimm R, Lebrilla CB et al. Glycoprofiling of bifidobacteria! consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J Agric Food Chem 2007;55:8914-9. (Pubitemid 350105536)
38. Kitaoka M, Tian J, Nishimoto M. Novel putative galactose operon involving lacto-N-biose Phosphorylase in Bifidobacterium longum. Appl Environ Microbiol 2005;71:3158-62. (Pubitemid 40807225)
39. Wada J, Ando T, Kiyohara M, Ashida H, Kitaoka M, Yamaguchi M et al. Bifidobacterium bifidum lactoN-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl Environ Microbiol 2008;74:3996-4004. (Pubitemid 351962424)
40. Miwa M, Horimoto T, Kiyohara M, Katayama T, Kitaoka M, Ashida H et al. Cooperation of beta-galactosidase and beta-N-acetylhexosaminidase from bifidobacteria in assimilation of human milk oligosaccharides with type 2 structure. Glycobiology 2010;20:1402-9.
41. Marcobal A, Barboza M, Froehlich JW, Block DE, German JB, Lebrilla CB et alo. Consumption of human milk oligosaccharides by gut-related microbes. J Agric Food Chem 2010;58:5334-40.
42. Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, Whitehead TR et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proceedings of the National Academy of Sciences of the United States of America 2008;105:18964-9.
43. Yoshida E, Sakurama H, Kiyohara M, Nakajima M, Kitaoka M, Ashida H et al. Bifidobacterium longum subsp. infantis uses two different (beta]-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides. Glycobiology 2011 [Epub ahead of print].
44. Sonnenburg ED, Zheng H, Joglekar P, Higginbottom SK, Firbank SJ, Bolam DN et al. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell 2010;141:1241-52.
45. Marcobal A, Barboza M, Sonnenburg ED, Pudlo N, Martens EC, Desai P et al. Bacteroides in the Infant Gut Consume Milk Oligosaccharides via Mucus-Utilization Pathways. Cell Host Microbe 2011;10:507-14.
46. Schwab C, Ganzle M. Lactic acid bacteria fermentation of human milk oligosaccharide components, human milk oligosaccharides and galactooligosaccharides. FEMS Microbiology Letters 2011; 315: 141-8.
47. Coppa GV, Gabrielli O, Zampini L, Galeazzi T, Ficcadenti A, Padella L et al. Oligosaccharides in 4 different milk groups, Bifidobacteria, and Ruminococcus obeum. J Pediatr Gastroenterol Nutr 2011;53.80-7.
48. Hunt KM, Foster JA, Forney LJ, Schutte UM, Beck DL, Abdo Z et al. Characterization of the diversity and temporal stability of bacterial communities in human milk. PloS one 2011;6:e21313.
49. Newburg DS, Pickering LK, McCluer RH, Cleary TG. Fucosylated oligosaccharides of human milk protect suckling mice from heat-stabile enterotoxin of Escherichia coli. J Infect Dis 1990;162:1075-80. (Pubitemid 20353586)
50. Coppa GV, Zampini L, Galeazzi T, Facinelli B, Ferrante L, Capretti R et al. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res 2006;59:377-82. (Pubitemid 43740074)
51. Morrow AL, Ruiz-Palacios GM, Altaye M, Jiang X, Guerrero ML, Meinzen-Derr JK et al. Human milk oligosaccharide blood group epitopes and innate immune protection against Campylobacter and calicivirus diarrhea in breastfed infants. Adv Exp Med Biol 2004;554:443-6. (Pubitemid 39304556)
52. Idanpaan-Heikkila I, Simon PM, Zopf D, Vullo T, Cahill P, Sokol K et al. Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia. J Infect Dis 1997;176:704-12. (Pubitemid 27360537)
53. Mysore JV, Wigginton T, Simon PM, Zopf D, Heman-Ackah LM, Dubois A. Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound. Gastroenterology 1999;117:1316-25.
54. Hong P, Ninonuevo MR, Lee B, Lebrilla C, Bode L. Human milk oligosaccharides reduce HIV-1-gp120 binding to dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN). Br J Nutr 2009;101:482-6.
55. Angeloni S, Ridet JL, Kusy N, Gao H, Crevoisier F, Guinchard S et al. Glycoprofiling with micro-arrays of glycoconjugates and lectins. Glycobiology 2005;15:31-41. (Pubitemid 40202037)
56. Kuntz S, Rudloff S, Kunz C. Oligosaccharides from human milk influence growth-related characteristics of intestinally transformed and non-transformed intestinal cells. Br J Nutr 2008;99:462-71. (Pubitemid 351223413)
57. Foxall C, Watson SR, Dowbenko D, Fennie C, Lasky LA, Kiso M et al. The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide. J Cell Biol 1992;117:895-902.
58. Phillips ML, Nudelman E, Gaeta FC, Perez M, Singhal AK, Hakomori S et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 1990;250:1130-2. (Pubitemid 120031820)
59. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-14. (Pubitemid 24046692)
60. Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS, Klein NJ. Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol 1999;106:391-9. (Pubitemid 29450663)
61. Bode L, Kunz C, Muhly-Reinholz M, Mayer K, Seeger W, Rudloff S. Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides. Thromb Haemost 2004;92:1402-10. (Pubitemid 39642553)
62. Bode L, Rudloff S, Kunz C, Strobel S, Klein N. Human milk oligosaccharides reduce platelet-neutrophil complex formation leading to a decrease in neutrophil beta 2 integrin expression. J Leukoc Biol 2004;76:820-6. (Pubitemid 39313718)
63. de Kivit S, Kraneveld AD, Garssen J, Willemsen LE. Glycan recognition at the interface of the intestinal immune system: Target for immune modulation via dietary components. Eur J Pharmacol 2011;668:S124-32.
64. Atochina O, Da'dara AA, Walker M, Ham DA. The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo. Immunology 2008;125:111-21.
65. Atochina O, Harn D. Prevention of psoriasis-like lesions development in fsn/fsn mice by helminth glycans. Exp Dermatol 2006;15:461-8.
66. Eiwegger T, Stahl B, Haidl P, Schmitt J, Boehm G, Dehlink E et al. Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties. Pediatr Allergy Immunol 2010;21:1179-88.
67. Eiwegger T, Stahl B, Schmitt J, Boehm G, Gerstmayr M, Pichler J et al. Human milk-derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr Res 2004;56:536-40. (Pubitemid 39280905)
68. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007;7:379-90. (Pubitemid 46674489)
69. Anderson JW, Johnstone BM, Remley DT. Breastfeeding and cognitive development: a meta-analysis. Am J Clin Nutr 1999;70:525-35.
70. Wang B, McVeagh P, Petocz P, Brand-Miller J. Brain ganglioside and glycoprotein sialic acid in breastfed compared with formula-fed infants. Am J Clin Nutr 2003;78:1024-9. (Pubitemid 39663481)
71. Morgan BL, Winick M. Effects of administration of N-acetylneuraminic acid (NANA) on brain NANA content and behavior. J Nutr 1980;110:416-24. (Pubitemid 10075543)
72. Wang B, Yu B, Karim M, Hu H, Sun Y, McGreevy P et al. Dietary sialic acid supplementation improves learning and memory in piglets. Am J Clin Nutr 2007;85:561-9. (Pubitemid 46220963)
73. Duncan PI, Raymond F, Fuerholz A, Sprenger N. Sialic acid utilisation and synthesis in the neonatal rat revisited. PloS one 2009;4:e8241.
74. Knol J, Scholtens P, Kafka C, Steenbakkers J, Gro S, Helm K et al. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr 2005;40:36-42. (Pubitemid 40180055)
75. Vos AP, Haarman M, van Ginkel JW, Knol J, Garssen J, Stahl B et al. Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice. Pediatr Allergy Immunol 2007;18:304-12. (Pubitemid 46961749)
76. Vos AP, Knol J, Stahl B, M'Rabet L, Garssen J. Specific prebiotic oligosaccharides modulate the early phase of a murine vaccination response. Int Immunopharmacol 2010;10:619-25.
77. Arslanoglu S, Moro GE, Boehm G. Early supplementation of prebiotic oligosaccharides protects formulafed infants against infections during the first 6 months of life. J Nutr 2007;137:2420-4. (Pubitemid 350058710)
78. Moro GArslanoglu SStahl BJelinek JWahn UBoehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 2006;91:814-9.
79. Gruber C, van Stuijvenberg M, Mosca F, Moro G, Chirico G, Braegger CP et al. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol 2010;126:791-7.
80. Arslanoglu SMoro GESchmitt JTandoi LRizzardi SBoehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 2008;138:1091-5.
81. Schouten B, Van Esch BC, Kormelink TG, Moro GE, Arslanoglu S, Boehm G et al. Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy. Pediatr Allergy Immunol 2011;22:537-42.
82. Barrat E, Michel C, Poupeau G, David-Sochard A, Rival M, Pagniez A et al. Supplementation with galactooligosaccharides and inulin increases bacterial translocation in artificially reared newborn rats. Pediatr Res 2008;64:34-9.
83. Leforestier G, Blais A, Blachier F, Marsset-Baglieri A, Davila-Gay AM, Perrin E et al. Effects of galactooligosaccharide ingestion on the mucosa-associated mucins and sucrase activity in the small intestine of mice. Eur J Nutr 2009;48:457-64.
84. Kleessen B, Hartmann L, Blaut M. Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br J Nutr 2003,89:597-606. (Pubitemid 36592087)
85. Westerbeek EA, van den Berg A, Lafeber HN, Fetter WP, van Elburg RM. The effect of enteral supplementation of a prebiotic mixture of non-human milk galacto-, fructo- and acidic oligosaccharides on intestinal permeability in preterm infants. Br J Nutr 2011;105:268-74.
86. Uauy RD, Fanaroff AA, Korones SB, Phillips EA, Phillips JB, Wright LL. Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1991;119:630-8.
87. Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Crussi F. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003;6.6-23.
88. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990;336:1519-23.